
Loading...
Latest notifications, circulars, orders and compliance changes.
Subject
Drug Price Control Revision for Coronary Stents Effective April 2026Summary: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has issued a notification revising the ceiling price of Coronary Stents. This update continues a series of price fixation orders issued since 2018 under the Drugs (Prices Control) Order (DPCO), 2013. The revision is based on the Wholesale Price Index (WPI) increase of 0.64956% for the year 2025 over 2024. Accordingly, the revised ceiling prices (exclusive of GST) will come into effect from 01 April 2026. Manufacturers and importers are permitted to adjust the Maximum Retail Price (MRP) where it is below the ceiling price, strictly in line with Paragraph 16(2) read with Paragraph 13(2) of DPCO, 2013. Further, GST can only be added if actually paid or payable. Retailers and dealers must display updated price lists prominently as per Para 24(4). Non-compliance with ceiling price norms will attract recovery of overcharged amounts along with interest under DPCO, 2013, and the Essential Commodities Act, 1955.
Subject
Draft Amendment to Drugs Rules Removes Viral Testing RequirementSummary: The Central Government has issued draft rules to amend the Drugs Rules, 1945, under the authority of the Drugs and Cosmetics Act, 1940. The proposal has been released after consultation with the Drugs Technical Advisory Board and is currently open for public comments. According to the draft notification published by the Ministry of Health and Family Welfare, the amendment targets Schedule F, Part XII-C, Para G of the Drugs Rules, 1945. The government has proposed to remove the provision that requires final pharmaceutical products to be tested for HIV-I antibodies, HIV-II antibodies, Hepatitis B surface antigen, and Hepatitis C virus antibodies. The draft rule specifically states that the sentence mandating these viral testing requirements will be omitted from the regulation. This proposed change forms part of the government’s ongoing efforts to update and streamline pharmaceutical regulatory provisions. Stakeholders, pharmaceutical companies, and industry experts may submit objections or suggestions within 30 days from the date the Gazette of India notification is made available to the public. After reviewing the feedback, the government will finalize the amendment and announce the effective date through the Official Gazette.
Subject
DGFT Extends Annual RoDTEP Return Filing Deadline to 31 March 2026Summary: The Directorate General of Foreign Trade (DGFT), under the powers of the Foreign Trade Policy 2023, has extended the deadline for filing Annual RoDTEP Returns (ARR) for the Financial Year 2023-24. Exporters can now submit their ARR until 31st March 2026 by paying a composition fee of Rs 15,000. Non-filing beyond this date may lead to actions under para 4.94 of the Handbook of Procedures 2023, including denial of RoDTEP benefits and scrolling out of scrips. This extension focuses on enhancing the ease of doing business and export promotion, giving exporters additional time to comply. Exporters are encouraged to complete filings within the extended period to avoid penalties and safeguard their RoDTEP entitlements.
Subject
DGFT Revises Import Policy for Platinum Articles under ITC (HS) 71141920Summary: The Directorate General of Foreign Trade ( DGFT ) has issued Notification S.O. 577(E) amending the import policy for ITC (HS) Code 71141920, covering articles of platinum under Chapter 71 of ITC (HS) 2022. Exercising powers under Sections 3 and 5 of the Foreign Trade (Development & Regulation) Act, 1992, read with the Foreign Trade Policy, 2023, the Central Government has revised the import status of these goods with immediate effect. Earlier classified as “Free”, the import of platinum articles has now been shifted to the “Restricted” category. A new Policy Condition No. 6 has been introduced in Chapter 71 to regulate such imports. However, specific exemptions are provided. Imports will continue to be treated as “Free” in cases of the re-import of Indian-origin platinum articles that were sent abroad for exhibitions or export promotion tours, rejected, returned, or unsold goods, and goods re-imported for repair. This amendment reflects DGFT’s intent to strengthen import controls on precious metals while allowing legitimate trade-linked re-imports. The notification has been issued with the approval of the Minister of Commerce & Industry.
Subject
DGFT Revise Import Policy and Policy condition of UmbrellasSummary: The Directorate General of Foreign Trade ( DGFT ), under the Ministry of Commerce and Industry, has issued a Notification dated 5 February 2026, introducing significant changes to the import policy governing umbrellas and sun umbrellas classified under Chapter 66 of ITC (HS) 2022. Under this amendment, the import policy for finished umbrellas falling under HS Code 66019100 (umbrellas with telescopic shaft) and HS Code 66019900 (other umbrellas) has been revised from Free to Restricted. This change reflects the government’s intent to regulate low-value imports and protect domestic manufacturers from price undercutting due to cheaper foreign products. However, the notification provides an important relaxation. Imports of umbrellas under the above HS codes will continue to be treated as “Free” if the CIF value is Rs. 100 or more per piece. This effectively introduces a Minimum Import Price (MIP) threshold, ensuring that only higher-value imports enter the Indian market without restriction. Further, the DGFT has clarified that the MIP condition will not apply to imports made by Advance Authorisation holders, Export Oriented Units (EOUs), and Special Economic Zone (SEZ) units, provided that such imported umbrellas are not sold in the Domestic Tariff Area (DTA). This exemption supports export-oriented manufacturing and maintains the competitiveness of Indian exporters.
Subject
DGFT Update: Plant Quarantine Second Amendment Order 2026 on Kratom ImportsSummary: The Central Government has notified the Plant Quarantine (Regulation of Import into India) (Second Amendment) Order, 2026, exercising powers under Section 3(1) of the Destructive Insects and Pests Act, 1914. The amendment comes into force from the date of publication in the Official Gazette and updates Schedule VI of the Plant Quarantine Order, 2003. A key change has been introduced at S. No. 687, concerning Mitragyna speciosa (Kratom Leaves). The existing import entries have been renumbered, and a new category has been added. The amendment now permits the import of dried Mitragyna speciosa leaves for processing, with Uganda specified as the country of origin. Notably, no additional declarations are required to be included in the Phytosanitary Certificate for this category. However, strict special import conditions apply. The consignment must be free from soil, quarantine weed seeds, and other plant debris, ensuring biosecurity compliance. This update provides clarity for importers, strengthens plant quarantine controls, and aligns regulated imports with India’s plant health and trade compliance framework.
Subscribe to Us
Find different law updates directly in your inbox. Subscribe now.